Cargando…
Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418674/ https://www.ncbi.nlm.nih.gov/pubmed/32771989 http://dx.doi.org/10.1136/bmjopen-2020-038128 |
_version_ | 1783569736226832384 |
---|---|
author | Dikeocha, Ifeoma Julieth Al-Kabsi, Abdelkodose Mohammed Hussin, Salasawati Alshawsh, Mohammed Abdullah |
author_facet | Dikeocha, Ifeoma Julieth Al-Kabsi, Abdelkodose Mohammed Hussin, Salasawati Alshawsh, Mohammed Abdullah |
author_sort | Dikeocha, Ifeoma Julieth |
collection | PubMed |
description | INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and Bifidobacterium as well as probiotic containing foods (kombucha, kefir, miso etc) have received lots of attention as anticancer agents for prevention and treatment. The effects of the administration of probiotics to patients with colorectal cancer is the primary goal of this systematic review. The overall aim is to assess how the use of probiotics in patients with colorectal cancer helps in the management of colorectal cancer and its effect on the diversity of gut microbiota. The final systematic review will provide a comprehensive evidence base for the use and efficacy of probiotics in patient with colorectal cancer care. METHODS AND ANALYSIS: The systematic review, will be conducted by extensively searching different databases such as PubMed, Web of Science, Scopus, Wiley and ProQuest to identify randomised controlled trials (with no time frame) which relate to the administration of probiotics to patients with colorectal cancer. The search strategy will include words like colorectal cancer, probiotics, Bifidobacterium, clinical trials etc. A systematic search of databases was performed between 17 and 20 January 2020. Two reviewers will independently review the studies and also search the reference lists of the eligible studies to obtain more references. Data will be extracted from the eligible studies using standardised data extraction form. After assessing the risk of bias, qualitative analysis will be used to synthesise the systematic review. ETHICS AND DISSEMINATION: This is a protocol for a systematic review; therefore, it doesn’t require any ethics approval. We intend to disseminate the protocol in a peer reviewed journal. |
format | Online Article Text |
id | pubmed-7418674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74186742020-08-18 Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies Dikeocha, Ifeoma Julieth Al-Kabsi, Abdelkodose Mohammed Hussin, Salasawati Alshawsh, Mohammed Abdullah BMJ Open Oncology INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and Bifidobacterium as well as probiotic containing foods (kombucha, kefir, miso etc) have received lots of attention as anticancer agents for prevention and treatment. The effects of the administration of probiotics to patients with colorectal cancer is the primary goal of this systematic review. The overall aim is to assess how the use of probiotics in patients with colorectal cancer helps in the management of colorectal cancer and its effect on the diversity of gut microbiota. The final systematic review will provide a comprehensive evidence base for the use and efficacy of probiotics in patient with colorectal cancer care. METHODS AND ANALYSIS: The systematic review, will be conducted by extensively searching different databases such as PubMed, Web of Science, Scopus, Wiley and ProQuest to identify randomised controlled trials (with no time frame) which relate to the administration of probiotics to patients with colorectal cancer. The search strategy will include words like colorectal cancer, probiotics, Bifidobacterium, clinical trials etc. A systematic search of databases was performed between 17 and 20 January 2020. Two reviewers will independently review the studies and also search the reference lists of the eligible studies to obtain more references. Data will be extracted from the eligible studies using standardised data extraction form. After assessing the risk of bias, qualitative analysis will be used to synthesise the systematic review. ETHICS AND DISSEMINATION: This is a protocol for a systematic review; therefore, it doesn’t require any ethics approval. We intend to disseminate the protocol in a peer reviewed journal. BMJ Publishing Group 2020-08-07 /pmc/articles/PMC7418674/ /pubmed/32771989 http://dx.doi.org/10.1136/bmjopen-2020-038128 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Oncology Dikeocha, Ifeoma Julieth Al-Kabsi, Abdelkodose Mohammed Hussin, Salasawati Alshawsh, Mohammed Abdullah Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title | Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title_full | Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title_fullStr | Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title_full_unstemmed | Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title_short | Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
title_sort | role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418674/ https://www.ncbi.nlm.nih.gov/pubmed/32771989 http://dx.doi.org/10.1136/bmjopen-2020-038128 |
work_keys_str_mv | AT dikeochaifeomajulieth roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies AT alkabsiabdelkodosemohammed roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies AT hussinsalasawati roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies AT alshawshmohammedabdullah roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies |